Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Bismuth subgallate

Introduction


Bismuth subgallate, with a chemical formula C7H5BiO6, is the active ingredient in the over-the-counter medicine, Devrom that is an internal deodorant commonly used to treat malodor by deodorizing flatulence and stool. Also, it has been used to treat Helicobacter pylori infection and is used in wound therapy. As an internal deodorant, it is commonly used by individuals who have had ostomy surgery, bariatric surgery, fecal incontinence, and irritable bowel syndrome.[1]
It can cause darkening of the tongue and stools, which is temporary and harmless. A reversible encephalopathy was noted and examined in subjects taking very large doses of Bismuth subgallate in a medical study. Authors concluded that it is unlikely that Bismuth subgallate was responsible for the illness. The neurological syndrome in the subjects does not resemble effects of bismuth when administered parenterally or by mouth.[2]

See also

See also

External links
  • American Cancer Society: Ileostomy Guide [[1]]
  • Cleveland Clinic-Having an Ileostomy– A Primer for New Ostomates[[2]]
  • United Ostomy Association of America-Ileostomy Guide[[3]]
  • The Ostomy Files:The Issue of Oral Medications and a Fecal Ostomy [[4]]
  • Devrom website[[5]]
References

References

  1. ↑ Gorbach S. L. (1990). “Bismuth therapy in gastrointestinal diseases”. Gastroenterology. 99 (3): 863–75. PMID 2199292.
  2. ↑ Burns R., Thomas D. W., Barron V. J. (1974). “Reversible encephalopathy possibly associated with bismuth subgallate ingestion”. BRITISH MEDICAL JOURNAL. 9 (1): 220–3. PMID 4818163.